Treatment with WNT5A doubled the ratio of phosphorylated to un-phosphorylated PIK3CA, showing that this non-canonical WNT pathway also operates in MCF7 breast cancer cells (Figure 4A). Here, WNT5A is linked to breast carcinoma.